Luteolyn
Alternative Names: Luteolin 5-rutinosideLatest Information Update: 05 Jul 2001
At a glance
- Originator Funakoshi
- Class Anti-inflammatories; Antineoplastics; Flavonoids
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetes mellitus
Most Recent Events
- 05 Jul 2001 Discontinued-Preclinical for Diabetes mellitus in Spain (Unknown route)
- 03 Aug 1998 No-Development-Reported for Diabetes mellitus in Spain (Unknown route)
- 29 Jul 1998 No-Development-Reported for Cancer in Japan (Unknown route)